0.5085  0.019 (3.8%)		04-24 16:00
Open: 0.5249 High: 0.5275 Volume: 1,728,989		Pre. Close: 0.4899 Low: 0.4827 Market Cap: 33(M)

Short term
Mid term
Targets	6-month :	0.8	1-year :	1.02
Resists	First :	0.68	Second :	0.87
Pivot price	0.61
Supports	First :	0.37	Second :	0.31
MAs	MA(5) :	0.47	MA(20) :	0.65
	MA(100) :	0.69	MA(250) :	0.63
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	23.2	D(3) :	16.1
RSI	RSI(14): 38.7
52-week	High :	2.27	Low :	0.16

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ICU ] has closed above bottom band by 24.4%. Bollinger Bands are 20.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.53 - 0.53	0.53 - 0.53
Low:	0.48 - 0.48	0.48 - 0.48
Close:	0.5 - 0.51	0.51 - 0.51

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

Fri, 19 Apr 2024
MSN - MSN

Wed, 17 Apr 2024
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update - Yahoo Finance

Wed, 17 Apr 2024
ICU Stock Earnings: SeaStar Medical Holding Misses EPS for Q4 2023 - InvestorPlace

Thu, 11 Apr 2024
SeaStar Medical to Present at the Noble Capital Markets' - GlobeNewswire

Thu, 28 Mar 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding ... - PR Newswire

Thu, 29 Feb 2024
ICU Stock Quote Price and Forecast - CNN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	75 (M)
Shares Float	72 (M)
Held by Insiders	15.4 (%)
Held by Institutions	1.2 (%)
Shares Short	3,590 (K)
Shares Short P.Month	4,110 (K)

EPS	-1.22
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.29
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-267.4 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-10 (M)
Levered Free Cash Flow	-15 (M)

PE Ratio	-0.43
PEG Ratio	0
Price to Book value	-1.76
Price to Sales	0
Price to Cash Flow	-3.73

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.